Not available outside of the UK & Ireland.
Application
RN-1734 has been used as a transient receptor potential vanilloid 4 (TRPV4) blocker to study its effects on differentiation of a corneal epithelial cell model, RCE1(5T5) cells.
Biochem/physiol Actions
RN-1734 is a selective TRPV4 antagonist.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: